| CXSL1300034 | 注射用重组人尿激酶原 | recombinant human pro-urokinase | Lyophilized | Biological Products(1) | New Drug Application | 2013-10-15 | 上海天士力药业有限公司 | Shanghai Tasly Pharmaceutical Co Ltd | Certificate Issued | 2016-05-31 | view |
| CXSL1400089 | 注射用重组人尿激酶原 | recombinant human pro-urokinase | Lyophilized | Biological Products(1) | New Drug Application | 2014-11-17 | 上海天士力药业有限公司 | Shanghai Tasly Pharmaceutical Co Ltd | Certificate Issued | 2015-12-24 | view |
| CXSL1500066 | 注射用重组人尿激酶原 | recombinant human pro-urokinase | Lyophilized | Biological Products(1) | New Drug Application | 2015-08-20 | 上海天士力药业有限公司 | Shanghai Tasly Pharmaceutical Co Ltd | Certificate Issued | 2016-11-17 | view |
| CXSL1900082 | 培重组人成纤维细胞生长因子21注射液 | | Injection | Biological Products(1) | New Drug Application | 2019-08-01 | 天士力生物医药股份有限公司 | Shanghai Tasly Pharmaceutical Co Ltd | In Review | 2019-07-30 | view |
| CXSL2000019 | 重组全人源抗PCSK9单克隆抗体注射液 | | Injection | Biological Products(1) | New Drug Application | 2020-02-14 | 天士力生物医药股份有限公司 | Shanghai Tasly Pharmaceutical Co Ltd | In Review | 2020-02-13 | view |
| CXSL2200226 | B1962注射液 | AP-505 | Injection | Biological Products(1) | New Drug Application | 2022-05-27 | | Shanghai Tasly Pharmaceutical Co Ltd | | | view |
| CXSL2300469 | B1344 注射液 | B-1344 | Injection | Biological Products(1) | New Drug Application | 2023-07-12 | | Shanghai Tasly Pharmaceutical Co Ltd | | | view |
| CXSS0600028 | 注射用重组人尿激酶原 | recombinant human pro-urokinase | Lyophilized | Biological Products(1) | New Drug Application | 2006-03-13 | 上海天士力药业有限公司 | Shanghai Tasly Pharmaceutical Co Ltd | Certificate Issued | 2006-11-29 | view |
| CXSS0700070 | 注射用重组人尿激酶原 | recombinant human pro-urokinase | Lyophilized | Biological Products | New Drug Application | 2008-02-18 | 上海天士力药业有限公司 | Shanghai Tasly Pharmaceutical Co Ltd | Certificate Issued | 2011-04-15 | view |
| CXSS2100013 | 注射用重组人尿激酶原 | recombinant human pro-urokinase | Lyophilized | Biological Products(2.2) | New Drug Application | 2021-02-03 | 天士力生物医药股份有限公司 | Shanghai Tasly Pharmaceutical Co Ltd | In Review | 2021-02-02 | view |
| CXSS2101040 | 注射用重组人尿激酶原 | recombinant human pro-urokinase | Lyophilized | Biological Products(2.2) | New Drug Application | 2021-10-21 | | Shanghai Tasly Pharmaceutical Co Ltd | | | view |
| CXSS2400083 | 注射用重组人尿激酶原 | recombinant human pro-urokinase | Lyophilized | Biological Products(2.2) | New Drug Application | 2024-08-07 | | Shanghai Tasly Pharmaceutical Co Ltd | | | view |
| CYSB1900006 | 注射用重组人尿激酶原 | recombinant human pro-urokinase | Lyophilized | Biological Products | Supplementary Application | 2019-01-23 | 天士力生物医药股份有限公司 | Shanghai Tasly Pharmaceutical Co Ltd | Certificate Issued | 2020-03-13 | view |
| CYSB2000040 | 注射用重组人尿激酶原 | recombinant human pro-urokinase | Lyophilized | Biological Products | Supplementary Application | 2020-03-12 | 天士力生物医药股份有限公司 | Shanghai Tasly Pharmaceutical Co Ltd | In Review | 2020-03-11 | view |
